Farallon Capital Management, Millennium Management, Magnetar and Ziff Capital are among the growing number of hedge funds, private equity firms and mutual fund companies investing in private placement rounds with biotech startups in this week's Alts Watch Healthcare Beat.
We tracked a total of three deals involving $300 million in fresh capital in the shortened holiday week ending December 27. The focus ranged from clinical diagnostics, immunotherapies and the promise of "molecular" glue.
As always, here is our summary of who, what and why each company story is attracting attention.
Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
A pay-as-you-go plan to get you started
→ Instantly unlock all new and archived articles
→ Daily, weekly and monthly e-mail newsletters
→ Access to the weekly AW Deal Watch by AW Research
Get more for less - 20% discount over monthly
→ Everything in Monthly PLUS:
→ Access to articles and data from AW Research
→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators